BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tsai WS, Chen JS, Shao HJ, Wu JC, Lai JM, Lu SH, Hung TF, Chiu YC, You JF, Hsieh PS, Yeh CY, Hung HY, Chiang SF, Lin GP, Tang R, Chang YC. Circulating Tumor Cell Count Correlates with Colorectal Neoplasm Progression and Is a Prognostic Marker for Distant Metastasis in Non-Metastatic Patients. Sci Rep 2016;6:24517. [PMID: 27075165 DOI: 10.1038/srep24517] [Cited by in Crossref: 80] [Cited by in F6Publishing: 78] [Article Influence: 13.3] [Reference Citation Analysis]
Number Citing Articles
1 Lai CH, Chang YC. Microfluidic Capture and Multiplex Immunofluorescence of Circulating Tumor Cells to Identify Cancer of Origin. Methods Mol Biol 2017;1634:1-19. [PMID: 28819837 DOI: 10.1007/978-1-4939-7144-2_1] [Reference Citation Analysis]
2 Dhandapani R, Sethuraman S, Subramanian A. Nanohybrids – cancer theranostics for tiny tumor clusters. Journal of Controlled Release 2019;299:21-30. [DOI: 10.1016/j.jconrel.2019.02.027] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
3 Tieng FYF, Abu N, Nasir SN, Lee LH, Ab Mutalib NS. Liquid Biopsy-Based Colorectal Cancer Screening via Surface Markers of Circulating Tumor Cells. Diagnostics (Basel) 2021;11:2136. [PMID: 34829483 DOI: 10.3390/diagnostics11112136] [Reference Citation Analysis]
4 Tan Y, Wu H. The significant prognostic value of circulating tumor cells in colorectal cancer: A systematic review and meta-analysis. Current Problems in Cancer 2018;42:95-106. [DOI: 10.1016/j.currproblcancer.2017.11.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
5 Pulikkathodi AK, Sarangadharan I, Hsu C, Chen Y, Hung L, Lee G, Chyi J, Lee G, Wang Y. Enumeration of circulating tumor cells and investigation of cellular responses using aptamer-immobilized AlGaN/GaN high electron mobility transistor sensor array. Sensors and Actuators B: Chemical 2018;257:96-104. [DOI: 10.1016/j.snb.2017.10.127] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 4.8] [Reference Citation Analysis]
6 Tsai Y, Yeh P, Huang C, Guo C, Chang Y. Scalable Multilayer Cell Collector to Capture Circulating Tumor Cells with an Unlimited Volume Capacity. ACS Biomater Sci Eng 2019;5:2725-31. [DOI: 10.1021/acsbiomaterials.9b00315] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Pimienta M, Edderkaoui M, Wang R, Pandol S. The Potential for Circulating Tumor Cells in Pancreatic Cancer Management. Front Physiol 2017;8:381. [PMID: 28626429 DOI: 10.3389/fphys.2017.00381] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
8 Schreier S, Triampo W. The Blood Circulating Rare Cell Population. What is it and What is it Good For? Cells 2020;9:E790. [PMID: 32218149 DOI: 10.3390/cells9040790] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
9 Palmirotta R, Lovero D, Cafforio P, Felici C, Mannavola F, Pellè E, Quaresmini D, Tucci M, Silvestris F. Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology. Ther Adv Med Oncol 2018;10:1758835918794630. [PMID: 30181785 DOI: 10.1177/1758835918794630] [Cited by in Crossref: 149] [Cited by in F6Publishing: 136] [Article Influence: 37.3] [Reference Citation Analysis]
10 Li W, Wang H, Zhao Z, Gao H, Liu C, Zhu L, Wang C, Yang Y. Emerging Nanotechnologies for Liquid Biopsy: The Detection of Circulating Tumor Cells and Extracellular Vesicles. Adv Mater 2019;31:e1805344. [PMID: 30589111 DOI: 10.1002/adma.201805344] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 8.3] [Reference Citation Analysis]
11 Dasgupta A, Lim AR, Ghajar CM. Circulating and disseminated tumor cells: harbingers or initiators of metastasis? Mol Oncol. 2017;11:40-61. [PMID: 28085223 DOI: 10.1002/1878-0261.12022] [Cited by in Crossref: 97] [Cited by in F6Publishing: 91] [Article Influence: 24.3] [Reference Citation Analysis]
12 Grewal S, Oosterling SJ, van Egmond M. Surgery for Colorectal Cancer: A Trigger for Liver Metastases Development? New Insights into the Underlying Mechanisms. Biomedicines 2021;9:177. [PMID: 33670204 DOI: 10.3390/biomedicines9020177] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Wu F, Zhu J, Mao Y, Li X, Hu B, Zhang D. Associations between the Epithelial-Mesenchymal Transition Phenotypes of Circulating Tumor Cells and the Clinicopathological Features of Patients with Colorectal Cancer. Dis Markers 2017;2017:9474532. [PMID: 29430076 DOI: 10.1155/2017/9474532] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
14 Malara N, Gentile F, Coppedè N, Coluccio ML, Candeloro P, Perozziello G, Ferrara L, Giannetto M, Careri M, Castellini A, Mignogna C, Presta I, Pirrone CK, Maisano D, Donato A, Donato G, Greco M, Scumaci D, Cuda G, Casale F, Ferraro E, Bonacci S, Trunzo V, Mollace V, Onesto V, Majewska R, Amato F, Renne M, Innaro N, Sena G, Sacco R, Givigliano F, Voci C, Volpentesta G, Guzzi G, Lavano A, Scali E, Bottoni U, Di Fabrizio E. Superhydrophobic lab-on-chip measures secretome protonation state and provides a personalized risk assessment of sporadic tumour. NPJ Precis Oncol 2018;2:26. [PMID: 30480095 DOI: 10.1038/s41698-018-0069-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
15 Economopoulou P, Georgoulias V, Kotsakis A. Classifying circulating tumor cells to monitor cancer progression. Expert Review of Molecular Diagnostics 2016;17:153-65. [DOI: 10.1080/14737159.2017.1275572] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
16 Ding Y, Li W, Wang K, Xu C, Hao M, Ding L. Perspectives of the Application of Liquid Biopsy in Colorectal Cancer. Biomed Res Int 2020;2020:6843180. [PMID: 32258135 DOI: 10.1155/2020/6843180] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
17 Bratulic S, Gatto F, Nielsen J. The Translational Status of Cancer Liquid Biopsies. Regen Eng Transl Med . [DOI: 10.1007/s40883-019-00141-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 4.3] [Reference Citation Analysis]
18 Gkountela S, Szczerba B, Donato C, Aceto N. Recent advances in the biology of human circulating tumour cells and metastasis. ESMO Open 2016;1:e000078. [PMID: 27843628 DOI: 10.1136/esmoopen-2016-000078] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
19 Gauthier A, Philouze P, Lauret A, Alphonse G, Malesys C, Ardail D, Payen L, Céruse P, Wozny A, Rodriguez-lafrasse C. Circulating Tumor Cell Detection during Neoadjuvant Chemotherapy to Predict Early Response in Locally Advanced Oropharyngeal Cancers: A Prospective Pilot Study. JPM 2022;12:445. [DOI: 10.3390/jpm12030445] [Reference Citation Analysis]
20 Chen F, Wang S, Fang Y, Zheng L, Zhi X, Cheng B, Chen Y, Zhang C, Shi D, Song H, Cai C, Zhou P, Xiong B. Feasibility of a novel one-stop ISET device to capture CTCs and its clinical application. Oncotarget. 2017;8:3029-3041. [PMID: 27935872 DOI: 10.18632/oncotarget.13823] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
21 Alhumaid A, AlYousef Z, Bakhsh HA, AlGhamdi S, Aziz MA. Emerging paradigms in the treatment of liver metastases in colorectal cancer. Crit Rev Oncol Hematol. 2018;132:39-50. [PMID: 30447926 DOI: 10.1016/j.critrevonc.2018.09.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
22 Snow A, Chen D, Lang JE. The current status of the clinical utility of liquid biopsies in cancer. Expert Rev Mol Diagn 2019;19:1031-41. [PMID: 31482746 DOI: 10.1080/14737159.2019.1664290] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
23 Xie Z, Gao X, Cheng K, Yu L. Correlation between the presence of circulating tumor cells and the pathologic type and staging of non-small cell lung cancer during the early postoperative period. Oncol Lett 2017;14:5825-30. [PMID: 29113213 DOI: 10.3892/ol.2017.6910] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
24 Ruiz-Rodríguez AJ, Molina-Vallejo MP, Aznar-Peralta I, González Puga C, Cañas García I, González E, Lorente JA, Serrano MJ, Garrido-Navas MC. Deep Phenotypic Characterisation of CTCs by Combination of Microfluidic Isolation (IsoFlux) and Imaging Flow Cytometry (ImageStream). Cancers (Basel) 2021;13:6386. [PMID: 34945008 DOI: 10.3390/cancers13246386] [Reference Citation Analysis]
25 Nanduri LK, Hissa B, Weitz J, Schölch S, Bork U. The prognostic role of circulating tumor cells in colorectal cancer.Expert Rev Anticancer Ther. 2019;19:1077-1088. [PMID: 31778322 DOI: 10.1080/14737140.2019.1699065] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
26 Chu PY, Hsieh CH, Wu MH. The Combination of Immunomagnetic Bead-Based Cell Isolation and Optically Induced Dielectrophoresis (ODEP)-Based Microfluidic Device for the Negative Selection-Based Isolation of Circulating Tumor Cells (CTCs). Front Bioeng Biotechnol 2020;8:921. [PMID: 32903713 DOI: 10.3389/fbioe.2020.00921] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
27 Delgado-Ureña M, Ortega FG, de Miguel-Pérez D, Rodriguez-Martínez A, García-Puche JL, Ilyine H, Lorente JA, Exposito-Hernandez J, Garrido-Navas MC, Delgado-Ramirez M, Serrano MJ. Circulating tumor cells criteria (CyCAR) versus standard RECIST criteria for treatment response assessment in metastatic colorectal cancer patients. J Transl Med 2018;16:251. [PMID: 30189880 DOI: 10.1186/s12967-018-1624-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
28 Mu HY, Ou YC, Chuang HN, Lu TJ, Jhan PP, Hsiao TH, Huang JH. Triple Selection Strategy for In Situ Labeling of Circulating Tumor Cells with High Purity and Viability toward Preclinical Personalized Drug Sensitivity Analysis. Adv Biosyst 2020;4:e2000013. [PMID: 32529799 DOI: 10.1002/adbi.202000013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Humphries HN, Wickremesekera SK, Marsh RW, Brasch HD, Mehrotra S, Tan ST, Itinteang T. Characterization of Cancer Stem Cells in Colon Adenocarcinoma Metastasis to the Liver. Front Surg 2017;4:76. [PMID: 29404335 DOI: 10.3389/fsurg.2017.00076] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
30 Bahnassy AA, Abdel-Azim YA, Ezzat S, Abdellateif MS, Zekri AN, Mohanad M, Salama A, Khaled H. The role of circulating tumor cells and K-ras mutations in patients with locally advanced rectal cancer: a prospective study. Mol Biol Rep 2020;47:9645-57. [PMID: 33174084 DOI: 10.1007/s11033-020-05973-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Chinen LTD, Abdallah EA, Braun AC, Flores BCTCP, Corassa M, Sanches SM, Fanelli MF. Circulating Tumor Cells as Cancer Biomarkers in the Clinic. Adv Exp Med Biol. 2017;994:1-41. [PMID: 28560666 DOI: 10.1007/978-3-319-55947-6_1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
32 Ozdemir A, Lin J, Gulfen M, Lai S, Hsiao C, Chen NG, Chen C. ESI MS for Microsized Bioparticles. Anal Chem 2017;89:13195-202. [DOI: 10.1021/acs.analchem.7b02937] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
33 Abdallah EA, Souza E Silva V, Braun AC, Gasparini VA, Kupper BEC, Tariki MS, Tarazona JGR, Takahashi RM, Aguiar Júnior S, Chinen LTD. A higher platelet-to-lymphocyte ratio is prevalent in the presence of circulating tumor microemboli and is a potential prognostic factor for non-metastatic colon cancer. Transl Oncol 2021;14:100932. [PMID: 33157516 DOI: 10.1016/j.tranon.2020.100932] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
34 Mielgo A, Schmid MC. Liver Tropism in Cancer: The Hepatic Metastatic Niche. Cold Spring Harb Perspect Med 2020;10:a037259. [PMID: 31548227 DOI: 10.1101/cshperspect.a037259] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
35 Castro-Giner F, Gkountela S, Donato C, Alborelli I, Quagliata L, Ng CKY, Piscuoglio S, Aceto N. Cancer Diagnosis Using a Liquid Biopsy: Challenges and Expectations. Diagnostics (Basel) 2018;8:E31. [PMID: 29747380 DOI: 10.3390/diagnostics8020031] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 12.5] [Reference Citation Analysis]
36 Lampis A, Ghidini M, Ratti M, Mirchev MB, Okuducu AF, Valeri N, Hahne JC. Circulating Tumour DNAs and Non-Coding RNAs as Liquid Biopsies for the Management of Colorectal Cancer Patients. GastrointestDisord 2020;2:212-35. [DOI: 10.3390/gidisord2030022] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
37 Harris EJ, Huang J, Carroll E, Lowe AC, Chau NG, Rabinowits G, Haddad R, Hanna GJ, Haddad T, Sanborn M, Kacew A, Lorch J. Circulating tumor cell analysis in locally advanced and metastatic squamous cell carcinoma of the head and neck. Laryngoscope Investig Otolaryngol 2020;5:1063-9. [PMID: 33364395 DOI: 10.1002/lio2.448] [Reference Citation Analysis]
38 Murray NP, Aedo S, Villalon R, Albarran V, Orrego S, Guzman E. Subtypes of minimal residual disease and outcome for stage II colon cancer treated by surgery alone. Ecancermedicalscience 2020;14:1119. [PMID: 33209110 DOI: 10.3332/ecancer.2020.1119] [Reference Citation Analysis]
39 Muşină A, Huţanu I, Zlei M, Ştefan M, Mentel M, Aniţei M, Filip B, Scripcariu DV, Gavrilescu M, Panuţa A, Buna-arvinte M, Radu I, Scripcariu V. Assessment of circulating tumor cells in peripheral blood using flow cytometry in patients with surgery for colorectal cancer – review. Revista Romana de Medicina de Laborator 2020;28:365-79. [DOI: 10.2478/rrlm-2020-0033] [Reference Citation Analysis]
40 Sut TN, Yoon BK, Jeon W, Jackman JA, Cho N. Supported lipid bilayer coatings: Fabrication, bioconjugation, and diagnostic applications. Applied Materials Today 2021;25:101183. [DOI: 10.1016/j.apmt.2021.101183] [Reference Citation Analysis]
41 Tsai W, Hung W, Wang T, Liu H, Yang C, Wu S, Hsu H, Hsiao Y, Tsai H, Tseng C. Circulating tumor cell enumeration for improved screening and disease detection of patients with colorectal cancer. Biomedical Journal 2020. [DOI: 10.1016/j.bj.2020.09.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
42 Kim H, Ahn YH, Kim BS, Park S, Yoon JC, Park J, Moon CM, Ryu DR, Lee Kang J, Choi JH, Park EM, Lee KE, Woo M, Kim M. Motion microscopy for label-free detection of circulating breast tumor cells. Biosens Bioelectron 2020;158:112131. [PMID: 32275204 DOI: 10.1016/j.bios.2020.112131] [Reference Citation Analysis]
43 Heidrich I, Abdalla TSA, Reeh M, Pantel K. Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as a Liquid Biopsy Marker in Colorectal Cancer. Cancers (Basel) 2021;13:4500. [PMID: 34572727 DOI: 10.3390/cancers13184500] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Ahmed MG, Abate MF, Song Y, Zhu Z, Yan F, Xu Y, Wang X, Li Q, Yang C. Isolation, Detection, and Antigen-Based Profiling of Circulating Tumor Cells Using a Size-Dictated Immunocapture Chip. Angew Chem Int Ed 2017;56:10681-5. [DOI: 10.1002/anie.201702675] [Cited by in Crossref: 80] [Cited by in F6Publishing: 73] [Article Influence: 16.0] [Reference Citation Analysis]
45 Li SP, Guan QL, Zhao D, Pei GJ, Su HX, Du LN, He JX, Liu ZC. Detection of Circulating Tumor Cells by Fluorescent Immunohistochemistry in Patients with Esophageal Squamous Cell Carcinoma: Potential Clinical Applications. Med Sci Monit. 2016;22:1654-1662. [PMID: 27184872 DOI: 10.12659/msm.898335] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
46 Vacante M, Ciuni R, Basile F, Biondi A. The Liquid Biopsy in the Management of Colorectal Cancer: An Overview. Biomedicines. 2020;8. [PMID: 32858879 DOI: 10.3390/biomedicines8090308] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
47 Dizdar L, Fluegen G, van Dalum G, Honisch E, Neves RP, Niederacher D, Neubauer H, Fehm T, Rehders A, Krieg A, Knoefel WT, Stoecklein NH. Detection of circulating tumor cells in colorectal cancer patients using the GILUPI CellCollector: results from a prospective, single-center study. Mol Oncol 2019;13:1548-58. [PMID: 31116510 DOI: 10.1002/1878-0261.12507] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
48 Jacobson RA, Munding E, Hayden DM, Levy M, Kuzel TM, Pappas SG, Masood A. Evolving Clinical Utility of Liquid Biopsy in Gastrointestinal Cancers. Cancers (Basel) 2019;11:E1164. [PMID: 31412682 DOI: 10.3390/cancers11081164] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
49 Lai C, Tsai W, Yang M, Chou T, Chang Y. A two-dimensional immunomagnetic nano-net for the efficient isolation of circulating tumor cells in whole blood. Nanoscale 2019;11:21119-27. [DOI: 10.1039/c9nr06256d] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
50 Ahrens TD, Bang-Christensen SR, Jørgensen AM, Løppke C, Spliid CB, Sand NT, Clausen TM, Salanti A, Agerbæk MØ. The Role of Proteoglycans in Cancer Metastasis and Circulating Tumor Cell Analysis. Front Cell Dev Biol 2020;8:749. [PMID: 32984308 DOI: 10.3389/fcell.2020.00749] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
51 Ahmed MG, Abate MF, Song Y, Zhu Z, Yan F, Xu Y, Wang X, Li Q, Yang C. Isolation, Detection, and Antigen-Based Profiling of Circulating Tumor Cells Using a Size-Dictated Immunocapture Chip. Angew Chem 2017;129:10821-5. [DOI: 10.1002/ange.201702675] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 3.4] [Reference Citation Analysis]
52 Sutton TL, Walker BS, Wong MH. Circulating Hybrid Cells Join the Fray of Circulating Cellular Biomarkers. Cell Mol Gastroenterol Hepatol 2019;8:595-607. [PMID: 31319228 DOI: 10.1016/j.jcmgh.2019.07.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
53 Tsai WS, Hung TF, Chen JY, Huang SH, Chang YC. Early Detection and Dynamic Changes of Circulating Tumor Cells in Transgenic NeuN Transgenic (NTTg) Mice with Spontaneous Breast Tumor Development. Cancers (Basel) 2021;13:3294. [PMID: 34209279 DOI: 10.3390/cancers13133294] [Reference Citation Analysis]
54 Micalizzi DS, Maheswaran S, Haber DA. A conduit to metastasis: circulating tumor cell biology. Genes Dev. 2017;31:1827-1840. [PMID: 29051388 DOI: 10.1101/gad.305805.117] [Cited by in Crossref: 148] [Cited by in F6Publishing: 141] [Article Influence: 29.6] [Reference Citation Analysis]
55 Lopez A, Harada K, Mizrak Kaya D, Dong X, Song S, Ajani JA. Liquid biopsies in gastrointestinal malignancies: when is the big day? Expert Review of Anticancer Therapy 2018;18:19-38. [DOI: 10.1080/14737140.2018.1403320] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
56 Zhang Y, Zarrabi K, Hou W, Madajewicz S, Choi M, Zucker S, Chen WT. Assessing Clinical Outcomes in Colorectal Cancer with Assays for Invasive Circulating Tumor Cells. Biomedicines 2018;6:E69. [PMID: 29882767 DOI: 10.3390/biomedicines6020069] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
57 Lai C, Choon Lim S, Wu L, Wang C, Tsai W, Wu H, Chang Y. Site-specific antibody modification and immobilization on a microfluidic chip to promote the capture of circulating tumor cells and microemboli. Chem Commun 2017;53:4152-5. [DOI: 10.1039/c7cc00247e] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 2.6] [Reference Citation Analysis]
58 Gao W, Chen Y, Yang J, Zhuo C, Huang S, Zhang H, Shi Y. Clinical Perspectives on Liquid Biopsy in Metastatic Colorectal Cancer. Front Genet 2021;12:634642. [PMID: 33584829 DOI: 10.3389/fgene.2021.634642] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Pereira LP, Silva P, Duarte M, Rodrigues L, Duarte CM, Albuquerque C, Serra AT. Targeting Colorectal Cancer Proliferation, Stemness and Metastatic Potential Using Brassicaceae Extracts Enriched in Isothiocyanates: A 3D Cell Model-Based Study. Nutrients 2017;9:E368. [PMID: 28394276 DOI: 10.3390/nu9040368] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 7.0] [Reference Citation Analysis]
60 Hamid FB, Lu CT, Matos M, Cheng T, Gopalan V, Lam AK. Enumeration, characterisation and clinicopathological significance of circulating tumour cells in patients with colorectal carcinoma. Cancer Genet 2021;254-255:48-57. [PMID: 33610860 DOI: 10.1016/j.cancergen.2021.02.002] [Reference Citation Analysis]
61 Norcic G. Liquid Biopsy in Colorectal Cancer-Current Status and Potential Clinical Applications. Micromachines (Basel) 2018;9:E300. [PMID: 30424233 DOI: 10.3390/mi9060300] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
62 Parisi A, Porzio G, Pulcini F, Cannita K, Ficorella C, Mattei V, Delle Monache S. What Is Known about Theragnostic Strategies in Colorectal Cancer. Biomedicines 2021;9:140. [PMID: 33535557 DOI: 10.3390/biomedicines9020140] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Yekula A, Muralidharan K, Rosh ZS, Youngkin AE, Kang KM, Balaj L, Carter BS. Liquid Biopsy Strategies to Distinguish Progression from Pseudoprogression and Radiation Necrosis in Glioblastomas. Adv Biosyst 2020;4:e2000029. [PMID: 32484293 DOI: 10.1002/adbi.202000029] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
64 Li N, Zhong D, Chen H, Huang T, Hou P, Zhang Y, Chen F, Wang X, Zhang H. The utility of folate receptor-positive circulating tumor cell in cancer diagnosis in the elderly population. Cancer Manag Res 2019;11:4097-107. [PMID: 31190982 DOI: 10.2147/CMAR.S184532] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
65 Chen C, Yang L, Rivandi M, Franken A, Fehm T, Neubauer H. Bioinformatic Identification of a Breast-Specific Transcript Profile. Proteomics Clin Appl 2020;14:e2000007. [PMID: 32558282 DOI: 10.1002/prca.202000007] [Reference Citation Analysis]
66 Tripathi P, Rao SX, Zeng MS. Clinical value of MRI-detected extramural venous invasion in rectal cancer. J Dig Dis. 2017;18:2-12. [PMID: 28009094 DOI: 10.1111/1751-2980.12439] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
67 Verbanac D, Čeri A, Hlapčić I, Shakibaei M, Brockmueller A, Krušlin B, Ljubičić N, Baršić N, Detel D, Batičić L, Rumora L, Somborac-Bačura A, Štefanović M, Ćelap I, Demirović A, Petlevski R, Petrik J, Grdić Rajković M, Hulina-Tomašković A, Rako I, Saso L, Barišić K. Profiling Colorectal Cancer in the Landscape Personalized Testing-Advantages of Liquid Biopsy. Int J Mol Sci 2021;22:4327. [PMID: 33919272 DOI: 10.3390/ijms22094327] [Reference Citation Analysis]
68 Gargalionis AN, Papavassiliou AG. Liquid Biopsies in Colorectal Cancer: Monitoring Genetic Heterogeneity. Trends Cancer 2017;3:166-8. [PMID: 28718430 DOI: 10.1016/j.trecan.2017.01.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
69 Bang-Christensen SR, Katerov V, Jørgensen AM, Gustavsson T, Choudhary S, Theander TG, Salanti A, Allawi HT, Agerbæk MØ. Detection of VAR2CSA-Captured Colorectal Cancer Cells from Blood Samples by Real-Time Reverse Transcription PCR. Cancers (Basel) 2021;13:5881. [PMID: 34884994 DOI: 10.3390/cancers13235881] [Reference Citation Analysis]
70 Aguilar-Avelar C, Soto-García B, Aráiz-Hernández D, Yee-de León JF, Esparza M, Chacón F, Delgado-Balderas JR, Alvarez MM, Trujillo-de Santiago G, Gómez-Guerra LS, Velarde-Calvillo LP, Abarca-Blanco A, Wong-Campos JD. High-Throughput Automated Microscopy of Circulating Tumor Cells. Sci Rep 2019;9:13766. [PMID: 31551445 DOI: 10.1038/s41598-019-50241-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
71 Carroll GM, Burns GL, Petit JA, Walker MM, Mathe A, Smith SR, Keely S, Pockney PG. Does postoperative inflammation or sepsis generate neutrophil extracellular traps that influence colorectal cancer progression? A systematic review. Surg Open Sci 2020;2:57-69. [PMID: 32754708 DOI: 10.1016/j.sopen.2019.12.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
72 Sand NT, Petersen TB, Bang-Christensen SR, Ahrens TD, Løppke C, Jørgensen AM, Gustavsson T, Choudhary S, Theander TG, Salanti A, Agerbæk MØ. Optimization of rVAR2-Based Isolation of Cancer Cells in Blood for Building a Robust Assay for Clinical Detection of Circulating Tumor Cells. Int J Mol Sci 2020;21:E2401. [PMID: 32244341 DOI: 10.3390/ijms21072401] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
73 Wang L, Zhou S, Zhang W, Wang J, Wang M, Hu X, Liu F, Zhang Y, Jiang B, Yuan H. Circulating tumor cells as an independent prognostic factor in advanced colorectal cancer: a retrospective study in 121 patients. Int J Colorectal Dis. 2019;34:589-597. [PMID: 30627849 DOI: 10.1007/s00384-018-03223-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
74 Abedini P, Fattahi A, Agah S, Talebi A, Beygi AH, Amini SM, Mirzaei A, Akbari A. Expression analysis of circulating plasma long noncoding RNAs in colorectal cancer: The relevance of lncRNAs ATB and CCAT1 as potential clinical hallmarks. J Cell Physiol. 2019;234:22028-22033. [PMID: 31093977 DOI: 10.1002/jcp.28765] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
75 Zhang D, Zhao L, Zhou P, Ma H, Huang F, Jin M, Dai X, Zheng X, Huang S, Zhang T. Circulating tumor microemboli (CTM) and vimentin+ circulating tumor cells (CTCs) detected by a size-based platform predict worse prognosis in advanced colorectal cancer patients during chemotherapy. Cancer Cell Int 2017;17:6. [PMID: 28070168 DOI: 10.1186/s12935-016-0373-7] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 9.2] [Reference Citation Analysis]
76 Zhang Y, Lv Y, Niu Y, Su H, Feng A. Role of Circulating Tumor Cell (CTC) Monitoring in Evaluating Prognosis of Triple-Negative Breast Cancer Patients in China. Med Sci Monit 2017;23:3071-9. [PMID: 28643770 DOI: 10.12659/msm.902637] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 3.4] [Reference Citation Analysis]
77 Worrede A, Meucci O, Fatatis A. Limiting tumor seeding as a therapeutic approach for metastatic disease. Pharmacol Ther 2019;199:117-28. [PMID: 30877019 DOI: 10.1016/j.pharmthera.2019.03.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
78 Tsai WS, You JF, Hung HY, Hsieh PS, Hsieh B, Lenz HJ, Idos G, Friedland S, Yi-Jiun Pan J, Shao HJ, Wu JC, Lai JM, Chang SE, Mei R, Watson D, Javey M, Nimgaonkar A. Novel Circulating Tumor Cell Assay for Detection of Colorectal Adenomas and Cancer. Clin Transl Gastroenterol 2019;10:e00088. [PMID: 31663904 DOI: 10.14309/ctg.0000000000000088] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
79 Deng Y, Zhang H, Zhang Z. What Is the Future of Circulating Tumor Cells in Colorectal Cancer? Curr Colorectal Cancer Rep 2018;14:207-16. [DOI: 10.1007/s11888-018-0418-5] [Reference Citation Analysis]
80 Smit DJ, Pantel K, Jücker M. Circulating tumor cells as a promising target for individualized drug susceptibility tests in cancer therapy. Biochem Pharmacol 2021;188:114589. [PMID: 33932470 DOI: 10.1016/j.bcp.2021.114589] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
81 Xue P, Zhang L, Guo J, Xu Z, Kang Y. Isolation and retrieval of circulating tumor cells on a microchip with double parallel layers of herringbone structure. Microfluid Nanofluid 2016;20. [DOI: 10.1007/s10404-016-1834-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
82 Garrido-Navas C, de Miguel-Perez D, Exposito-Hernandez J, Bayarri C, Amezcua V, Ortigosa A, Valdivia J, Guerrero R, Garcia Puche JL, Lorente JA, Serrano MJ. Cooperative and Escaping Mechanisms between Circulating Tumor Cells and Blood Constituents. Cells 2019;8:E1382. [PMID: 31684193 DOI: 10.3390/cells8111382] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
83 Gupta P, Gulzar Z, Hsieh B, Lim A, Watson D, Mei R. Analytical validation of the CellMax platform for early detection of cancer by enumeration of rare circulating tumor cells. J Circ Biomark 2019;8:1849454419899214. [PMID: 31921364 DOI: 10.1177/1849454419899214] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
84 Yadav A, Kumar A, Siddiqui MH. Detection of circulating tumour cells in colorectal cancer: Emerging techniques and clinical implications. World J Clin Oncol 2021; 12(12): 1169-1181 [DOI: 10.5306/wjco.v12.i12.1169] [Reference Citation Analysis]
85 Hu M, Wang Z, Wu Z, Ding P, Pei R, Wang Q, Xing C. Circulating tumor cells in colorectal cancer in the era of precision medicine. J Mol Med (Berl) 2021. [PMID: 34802071 DOI: 10.1007/s00109-021-02162-3] [Reference Citation Analysis]
86 Lu YJ, Wang P, Peng J, Wang X, Zhu YW, Shen N. Meta-analysis Reveals the Prognostic Value of Circulating Tumour Cells Detected in the Peripheral Blood in Patients with Non-Metastatic Colorectal Cancer. Sci Rep 2017;7:905. [PMID: 28424486 DOI: 10.1038/s41598-017-01066-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
87 Yang C, Zhuang W, Hu Y, Zhu L. Clinical significance of peripheral circulating tumor cell counts in colorectal polyps and non-metastatic colorectal cancer. World J Surg Oncol 2018;16:13. [PMID: 29357895 DOI: 10.1186/s12957-017-1305-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
88 Bahnassy AA, Salem SE, Mohanad M, Abulezz NZ, Abdellateif MS, Hussein M, Zekri CAN, Zekri AN, Allahloubi NMA. Prognostic significance of circulating tumor cells (CTCs) in Egyptian non-metastatic colorectal cancer patients: A comparative study for four different techniques of detection (Flowcytometry, CellSearch, Quantitative Real-time PCR and Cytomorphology). Exp Mol Pathol 2019;106:90-101. [PMID: 30578762 DOI: 10.1016/j.yexmp.2018.12.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]